US$ 22.09
fda approved glp-1 approves first generic for weight loss FDA Approves First Oral GLP-1
Description
These label expansions unlocked new pathways for coverage, and by early 2025 the proportion of Medicare patients with diabetes or obesity initiating GLP-1 therapy rose sharply

Diverticulosis does not cause symptoms, but if...

More patients are coming forward, claiming they lost thousands of dollars after purchasing what they believed were GLP-1 weight-loss drugs.

The class of drugs, which includes Novo Nordisks Ozempic and Wegovy, are associated with the risk of gastrointestinal adverse events when used for weight loss, finds a study published Thursday in JAMA.
Before anyone concludes compounded GLP-1s are better, thats not what this survey shows

The answer isn't the same for everyone
